Your browser doesn't support javascript.
loading
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity.
Yoshida, Akiho; Okamura, Shinya; Torii, Shiho; Komatsu, Sayuri; Miyazato, Paola; Sasaki, Hitomi; Ueno, Shiori; Suzuki, Hidehiko; Kamitani, Wataru; Ono, Chikako; Matsuura, Yoshiharu; Takekawa, Shiro; Yamanishi, Koichi; Ebina, Hirotaka.
Afiliação
  • Yoshida A; Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Okamura S; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Torii S; Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Komatsu S; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Miyazato P; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Sasaki H; Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan.
  • Ueno S; Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Suzuki H; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Kamitani W; Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Ono C; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Matsuura Y; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Takekawa S; Department of Infectious Diseases and Host Defense, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Yamanishi K; Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Ebina H; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
iScience ; 25(11): 105412, 2022 Nov 18.
Article em En | MEDLINE | ID: mdl-36320329

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article